A critical discovery in cancer investigation is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This crucial tumor inhibitor protein is frequently disabled in various types of tumors, leading https://7prbookmarks.com/story22023535/nanobodies-revive-p53-the-potential-approach-for-malignant-therapy